Home  |  About  MTRC  |  Research  |  People  |  News  |  Facilities  |  Resources  |  Site Map  |  Search  |  Contact  Us
  MTRC Director
Curriculum Vitae
Research Interests
Lab Members
Publications
Press Releases
Related Websites
Mail to Director
  Faculty & Staff
 Visiting Professor
 Research Faculty
 Faculty Directory
 Admin & Tech Staff
  For Visitors
 Guest Bulletin Board
 Korean        
Copyright ¨Ï 2000 MTRC

ÀÌ Á¦ È£ (Je-Ho Lee, M.D., Ph.D.)

PRESENT POST

    Director
    Molecular Therapy Research Center
    sponsored by Ministry of Science & Technology
    of the Korean Government

    Professor
    Department of Obstetrics & Gynecology
    Samsung Medical Center
    Sungkyunkwan Univ. School of Medicine
    Seoul, Korea

    E-Mail : jeholee@gmail.com
EDUCATION / POST GRADUATE TRAINING
    1973 : M.D. Seoul National University, Seoul, Korea
    1979 : M.S. (Medicine), Seoul National University, Seoul, Korea
    1984 : Ph.D. (Medicine) Seoul National University, Seoul, Korea

    1976 - 1977: Rotating Internship, Seoul Nat'l Univ. Hospital, Seoul, Korea
    1977 - 1981: Residency in Ob & Gyn., Seoul Nat'l Univ. Hospital, Seoul, Korea
APPOINTMEMTS / WORK EXPERIENCE
    1981 - Feb. 1994 :

    Senior Gynecologist
    Department of Obstetrics & Gynecology
    Director
    Laboratory of Biochemistry & Molecular Genetics
    Korea Cancer Center Hospital, Seoul, Korea

    1987 - 1989 :


    Postdoctoral Fellow, M.D. Anderson Cancer Center
    Houston, Texas

    May 1993 - Aug.1993 :


    Visiting Fellow, M.D. Anderson Cancer Center
    Houston, Texas

    Mar.1994 - Jun. 1998 :


    Director, Center for Clinical Research
    Samsung Biomedical Research Institute, Seoul, Korea

    Mar. 1994 - Mar. 2001 :





    Professor & Chairman
    Department of Obstetrics & Gynecology
    Samsung Medical Center
    SungKyunKwan Univ. School of Medicine
    Seoul, Korea

    Feb. 1999 - Oct. 2000 :




    Associate Director
    Clinical Research Institute
    Samsung Medical Center
    SungKyunKwan Univ. School of Medicine

    Nov. 2000 - Aug. 2001 :




    Director
    Clinical Research Institute
    Samsung Medical Center
    SungKyunKwan Univ. School of Medicine

    Feb. 1999 - Aug. 2001 :




    Director
    Gene Therapy Research Center
    Samsung Medical Center
    SungKyunKwan Univ. School of Medicine

    July 2000 - present :




    Director
    Molecular Therapy Research Center
    sponsored by Ministry of Science & Technology
    of the Korean Government

OTHER PROFESSIONAL APPOINTMENTS & ACHIEVEMENTS

    1994 - present :

      Executive member of Biomedical Science in R & D
      Committee Nat'l Council for Science and Technology

    1994 - 2000 :


      Chairman, Samsung Annual International Symposium
      Organizing Committee of the Samsung Biomedical
      Research Institute

    1996 - present : - Editor-in-Chief, Journal of Genetic Medicine

    - Vice President, Korean Society of Medical Genetics


    1997 - present :

    - Leading Initiator of the Telemedicine between M.D.
      Anderson Cancer Center in Houston, Texas and
      Samsung Medical Center in Seoul, Korea

    - Founder and Chairman, Korean Society of Gene Therapy

    - Chairman, GeneMed Network : Cyber Gene Therapy
      Information Service Network

    - President, ATI (Angel Technology & Information:
      Non-profit Cyber Health & Biomedical Technology
      Consulting Service Network)

    1998 - present :





    - Founding Member, International Molecular Biology Network
      (IMBN) for Asia and Pacific Rim

    - Editorial Board Member, Journal of Human Genetics
      (Official Journal of the Japan Society of Human Genetics)

    1999 - present : Member, National Advisory Committee of Molecular Medicine, Ministry of Science & Technology of Korea

    Member, National Advisory Committee of Medical Research, Ministry of Health & Welfare of Korea

    Member, National Selection Committee of Medical Research Projects, Ministry of Education of Korea

    Representative Member, Korea-America Medical Research Forum, OSTP (Office of Science & Technology Policy) of White House, USA and STEPI (Science & Technology Policy Institute) of Korea

    Member, Research & Development Sub-Committee of the National Science & Technology Committee, Ministry of Science & Technology of Korea

    2000 - present :

    - Executive Member of National Council of Bioethics

    2001 - present:

    - Member, Nanotechnology Committee, Ministry of Science
      & Technology of Korea
Special Note:
    My research paper titled "Allelotype of human ovarian cancer. Cancer Research (USA), 51:5118-5122, 1991" was one of the 10 most frequently referred and quoted Korean research papers in overseas (acknowledged by the Ministry of Science & Technology of Korea in 1998).

LICENSURE

    1973 :


    Licensed Medical Doctor (No.13276), Korean Society of Medical
    Association

    1973 :

    ECFMG Certificate (USA)

    1981 :

    Certified Gynecologist (No.1244), Korean Society of Obstetrics &
    Gynecology

PROFESSIONAL ORGANIZATION MEMBERSHIPS
  • Member, American Society of Gene Therapy, 1998-
  • Member, American Association of Cancer Research
  • Member, International Society for Differentiation & Development
  • Member, International Gynecologic Cancer Society, 1991-
  • Member of the Korean Association of Obstetricians & Gynecologists, 1981-
  • Member of the Korean Association of Cancer Prevention, 1996-
  • Member of the Korean Society of Gynecologic Oncology and Colposcopy, 1992-
  • Member of the Korean Cancer Association, 1981-
  • Member of the Korean Society of Gynecologic Endoscopy, 1989-
  • Member of the Korean Society of Ultrasound in Obstetrics & Gynecology, 1997-

RESEARCH ACTIVITIES
    1989 -1994 : Project Director
    Research Project on Molecular Genetics of Malignant Tumors
    Ministry of Science & Technology of the Korean Government

    1997 - 1999 : Principal Investigator
    Human Genome Project
    Ministry of Science & Technology of the Korean Government

    1991 - 2000 : Visiting Scientist
    Research Project on Molecular Genetics of Gynecologic Tumors
    Seoul National University Cancer Research Institute

    1994 - 2002 : Principal Investigator
    G-7 Research Project on Gene Therapy of Malignant Tumors
    Ministry of Science & Technology of the Korean Government

    2000 - present : Director
    Molecular Therapeutics Research Center
    sponsored by Ministry of Science & Technology of the Korean Government

PUBLICATIONS IN INTERNATIONAL PEER-REVIEW JOURNALS

  1. Kim JS, Lee SH, Cho YS, Choi JJ, Kim YH, Lee JH. Enhancement of the Adenoviral Sensitivity of Human Ovarian Cancer Cells by Transient Expression of Coxsackievirus and Adenovirus Receptor (CAR). Gynecol Oncol 85(2):260-5, 2002.

  2. Park J, Park K, Kim S, Lee JH. Msx1 Gene Overexpression Induces G1 Phase Cell Arrest in Human Ovarian Cancer Cell Line OVCAR3. Biochemical and Biophysical Research Communications 281:1234-1240, 2001.

  3. Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, Park CS, Kim DS, Lee JH. Aberrant Expression of cyclin D1 is Associated with Poor Prognosis in Early Stage Cervical Cancer of the Uterus. Gynecologic Oncology 81:341-347, 2001.

  4. Lee SH, Cho YS, Oh SH, Choi JJ, Lee JH. Aberrant expression of Smad4 results in resistance against the growth inhibitory effect of transforming growth factor-beta in SiHa, human cervical cancer cell line. Int J Cancer 94:500-507, 2001.

  5. Lee SH, Zhang W, Cho YS, Oh SH, Choi JJ, Lee JH. Overexpression of the Thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis. Oncogene 20:6700-6706, 2001.

  6. Kang-Park S, Lee JH,Shin JH, Lee YI. Activation of IGF-II Gene by HBV-X Protein Requires PKC and p44/p42 Map Kinase Signalings. Biochemical and Biophysical Research Communications 283:303-307, 2001.

  7. Kang WK, Park C, Yoon HL, Kim WS, Yoon SS, Lee MH, Park K, Kim K, Jeong HS, Kim JA, Nam SJ, Yang JH, Son YI, Baek CH, Han J, Ree HJ, Lee ES, Kim SH, Kim DW, Ahn YC, Huh SJ, Choe YH, Lee JH, Park MH, Kong GS, Park EY, Kang YK, Bang YJ, Paik NS, Lee SN, Kim SH, Kim S, Robbins PD, Tahara H, Lotze MT, Park CH. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a phase I study. Human Gene Therapy 12(6):671-84, 2001.

  8. Kim JS, Lee SH, Cho YS, Park K, Kim YH, Lee JH. Development of a packaging cell line for propagation of replication-deficient adenovirus vector. Exp Mol Med. 2001 Sep 30;33(3):145-9.

  9. Kim JS, Lee SH, Cho YS, Kim YH, Lee JH. Ectopic expression of the coxsackievirus and adenovirus receptor (CAR) increases susceptibility to adenoviral infection in the human cervical cancer cell line, SiHa. Biochemical and Biophysical Research Communications 288(1):240-244, 2001.

  10. Song MS, Park YK, Lee JH, Park K. Induction of Glucose-regulated Protein 78 by Chronic Hypoxia in Human Gastric Tumor Cells through a Protein Kinase C-r/ERK/AP-1 Signaling Cascade. Cancer Research 61:8322-8330, 2001.

  11. Choi D, Lee E, Hwang S, Jun K, Kim D, Yoon BK, Shin HS, Lee JH. The biological significance of phospholipase C beta 1 gene mutation in mouse sperm in the acrosome reaction, fertilization, and embryo development. J Assist Reprod Genet. 2001 May;18(5):305-10.

  12. Choi DS, Yoon S, Lee EY, Hwang SS, Yoon BK, Lee JH. The expression of pseudogene cyclin D2 mRNA in the human ovary may be a novel marker for decreased ovarian function associated with the aging process. J Assisted Reproduction and Genetics 18(2):112-115, 2001.

  13. Roh CR, Oh WJ, Yoon BK, Lee JH. Up-regulation of Matrix metalloproteinase-9 in human myometrium during labour : a cytokine-mediated process in uterine smooth muscle cells. Molecular Human Reproduction 6(1):96-102, 2000.

  14. Moon IJ, Lee Y, Kwak CS, Lee JH, Choi K, Schreiber AD, Park JG. Target Site Search and Effective Inhibition of Leukemic Cell Growth by Covalently-Closed Multiple Antisense (CMAS)-Oligonucleotides to c-myb. Biochem J 346: 295-303, 2000.

  15. Choi DS, Lee EY, Yoon S, Hwang SS, Yoon BK, Lee JH. Clinical Correaltion of Cyclin D2 mRNA Expression in Human Luteinized Granulosa Cells. J Assisted Reproduction and Genetics 17(10):574-579, 2000.

  16. Kim J, Hwang ES, Kim JS, You EH, Lee JH. Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse. Cancer Gene Therapy 6(2):172-178, 1999.

  17. Park CS, Joo IS, Song SY, Kim DS, Bae DS, Lee JH. An Immunohistochemical Analysis Of Heat Shock Protein 70, p53, and Estrogen Receptor Status in Carcinoma of the Uterine Cervix. Gynecologic Oncology 74:53-60, 1999.

  18. Hwang ES, Kim J, Kim JS, Kao C, Ko SC, Chung L, Lee JH. The effects of the adenovirus-mediated wild-type p53 delivery in human epithelial ovarian cancer cell lines in vitro and in vivo, Int J Gynecological Cancer 8:27-36, 1998.

  19. Shim C, Zhang W, Rhee CH, Lee JH. Profiling of differentially expressed genes in human primary cervical cancer by cDNA expression array. Clinical Cancer Research 4(12):3045-3050, 1998.

  20. Kim JH, Lee SH, Lee JH. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas. J Neuro-Oncology 40(2):101-106, 1998.

  21. Kim BG, Park SY, Kim JH, Lee JH, Lee ED, Lee KH, Park KB, Lee BH, Kim KH. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy. Gynecologic Oncology 63:105-113, 1996.

  22. Park W, Choi JJ, Hwang ES, Lee JH. Identification of a Variant Estrogen Receptor Lacking Exon 4 and its Coexpression with Wild-type Estrogen Receptor in Ovarian Carcinomas. Clinical Cancer Research 2:2029-2035, 1996.

  23. Lee JH, Kang YS, Park SY, Kim BG, Lee ED, Lee KH, Park KB. Expression of CD44R1 Adhesion Molecule in Primary and Metastatic Gynecologic Malignancies and Their Cell Lines. Int J Gynecologic Cancer 5:193-199, 1995.

  24. Park SY, Kang YS, Kim BG, Lee ED, Lee KH, Park KB, Lee JH. Loss of heterozygosity on chromosome 17p in human cervical carcinomas. Cancer Genet Cytogenet 79:74-78, 1995.

  25. Lee JH, Kang YS, Park SY, Kim BG, Lee ED, Lee KH, Park KB, Kavanagh JJ, Wharton JT. p53 Mutation in epithelial ovarian carcinoma and borderline ovarian tumor. Cancer Genet Cytogenet 85:43-50, 1995.

  26. Park SY, Kim BG, Kim JH, Lee JH, Lee ED, Lee KH, Park KB, Lee BH, Kim KH. Phase I/II study of neoadjuvant intra-arterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage lib bulky cervical carcinoma. Cancer 76(5):814-823, 1995.

  27. Lee JH, Kang YS, Park SY, Kim BG, Lee ED, Lee KH, Park KB. p53 mutation is rare in human cervical carcinomas with HPV-positive sequence. Int J Gynecologic Cancer 4:371-378, 1994.

  28. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y. Allelotype of human ovarian cancer. Cancer Research 51:5118-5122, 1991.

  29. Lee JH, Kavanagh JJ, Wharton JT, Wildrick D, Blick M. Frequent loss of heterozygosity on chromosome 6q, 11, and 17 in human ovarian carcinomas. Cancer Research 50:2724-2728, 1990.

  30. Lee JH, Kavanagh JJ, Wharton JT, Wildrick D, Blick M. Allele loss at the c-Ha-rasl locus in human ovarian cancer. Cancer Research 49:1220-1222, 1989.

Back to Top


MTRC, B4. Cancer Center. Samsung Medical Center, 50 Irwon-dong, Kangnam-ku, Seoul 135-710, Korea
Tel: +82-2-2148-7328   Fax: +82-2-2148-7379   E-mail: jeholee@gmail.com